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Objective: The cardioprotective effect of red wine has been attributed to resveratrol. The resveratrol-induced protection
against ischemia-reperfusion (I/R) injury has been documented in heart, kidney, and brain. Resveratrol scavenges free O2
radicals and upregulates nitric oxide (NO). However, the presence of resveratrol-induced spinal cord protection against
I/R injury has not been reported in the literature. The objective of this study was to evaluate the effects of resveratrol on
neurologic functions, histopathologic changes, and NO metabolism following temporary spinal cord ischemia (SCI) in
rabbits.
Material and methods: SCI was induced with occlusion of the infrarenal aorta in rabbits. In addition to the sham group
(group S, n  7), group C (n  7) received vehicle 30 minutes before ischemia. Group R1 (n  7) and R10 (n  7)
received 1 mg/kg and 10 mg/kg resveratrol instead of vehicle, respectively. Blood samples were taken to obtain
nitrite/nitrate levels during the surgical procedure. After neurologic evaluation at the 48th hour of reperfusion, lumbar
spinal cords were removed for histopathologic examination and malondialdehyde measurement as a marker of oxidative
stress.
Results: Five animals in group C had paraplegia while 5 in group R10 had normal neurologic functions. The average
Tarlov score of group R10 was significantly higher than that the score of group C (4.1  1.2, vs 1.2  2.2; P  .014).
Histopathologic examination revealed higher neuronal viability index in group R10 compared with that of group C (0.82
 0.24 vs. 0.46 0.34; P .018). Nitrite/nitrate levels decreased in group C (from 357 20.15mol/L to 281 47.9
mol/L; P < .01) whereas they increased both in group R1 and group R10 (from 28728 mol/L to 310  33.9
mol/L and from 296 106 mol/L to 339 87 mol/L, respectively) during SCI. Malondialdehyde levels of group
R10 was lower than those of group C (55  12.9 nmol/mg protein vs 83.9  15.1 nmol/mg protein; P  .001,
respectively).
Conclusions: In this model of SCI, resveratrol decreased oxidative stress, increased NO release, and protected spinal cord
from I/R injury. Resveratrol-induced neuroprotection is probably mediated by its antioxidant and NO promoting
properties. Before considering the clinical use of this natural antioxidant, further research is warranted about its
mechanism of effects, timing, and optimum dose. (J Vasc Surg 2004;40:138-45.)
Clinical Relevance: Paraplegia that results from spinal cord ischemia is a catastrophic complication of thoracic and
thoracoabdominal aorta surgical procedures. Despite several surgical modifications and pharmacologic approaches,
paraplegia has not been totally eliminated. On clinical grounds, the efficiency of currently used pharmacologic agents to
prevent spinal cord injury during thoracic and thoracoabdominal aorta surgery is very limited and their benefit is
controversial. Preischemic infusion of resveratrol protects the spinal cord from ischemia reperfusion injury in rabbits.
Following clarification of the underlying protective mechanism, optimal dose, and timing, resveratrol may used in
humans as an adjunct to eliminate this catastrophic complication.Paraplegia that results from spinal cord ischemia (SCI)
is a catastrophic complication of surgical procedures per-
formed on the thoracic and thoracoabdominal aorta. Neu-
rologic injury due to ischemia-reperfusion (I/R) injury of
the spinal cord has an incidence of between 2.9% and 23%.1
Despite several surgical modifications and pharmacologic
approaches, postoperative spinal cord dysfunction has not
been totally eliminated.2 Energy failure, excitotoxicity, and
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doi:10.1016/j.jvs.2004.03.032138oxidative stress have been implicated in the pathogenesis of
neurologic injury after SCI.3,4 Among these factors, the
role of oxidative stress becomes much greater with massive
production of free O2 radicals (FOR) in previously ischemic
tissue.5 In addition to these factors, there is an ongoing
controversy regarding the role of the nitric oxide (NO) in
neurotoxicity or neuroprotection following I/R of neural
tissues.6-9
Decreased cardiac mortality has been demonstrated in
regular consumers of red wine. This phenomenon was
referred as French paradox.10 This cardioprotection is at-
tributed to resveratrol, which is the active constituent of red
wine. Resveratrol has shown to upregulate NO and also to
inhibit peroxidation of membrane lipids, scavenge FOR,
inhibit platelet aggregation, and protect several organs
from I/R injury.11,12
The aim of this study is to evaluate if resveratrol admin-
istration can protect rabbit spinal cord from I/R injury. To
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we evaluated hind-limb motor functions and histopatho-
logic examination of the spinal cords. Furthermore, the
effects of resveratrol administration against oxidative stress
were evaluated via measurement of malondialdehyde
(MDA) level in spinal cord homogenates for estimation of
lipid peroxidation.
MATERIAL AND METHODS
Animal care
Fifty-two male New Zealand white rabbits weighing
2.0 to 3.5 kg were used in these experiments. The rabbits
were allowed access to standard rabbit food and water ad
libitum. All rabbits were neurologically intact before anes-
thesia. This work was approved by the local institutional
review board, and the animal care complied with the Na-
tional Research Council’s Guide for the Care and Use of
Laboratory Animals.
Anesthesia and monitoring. Animals were anesthe-
tized with intramuscular ketamine (50 mg/kg) and xyla-
zine (10 mg/kg), placed in the supine position, and al-
lowed to breathe spontaneously without mechanical
ventilation. Supplemental intravenous doses of ketamine
were administrated as needed throughout the experiments.
The core temperature was continuously monitored with a
rectal probe inserted 5 cm into the rectum. Rectal temper-
ature was maintained between 37°C to 38.5°C by a heating
lamp throughout the procedure. A catheter (24 gauge) was
sterilely placed in a marginal ear vein for intravenous drug
administration. Another catheter (24 gauge) was placed in
the central ear artery to monitor arterial blood pressure and
to obtain blood samples. Preoperative Cefazolin (10 mg/
kg) was given as a single dose. The heartbeat and arterial
blood pressure were continuously monitored throughout
the procedure.
Surgical procedure. All animals were prepared and
draped in a sterile fashion. After the rabbits had been
stabilized, a 10-cm-long median laparotomy was per-
formed. After reflection of intestine to the right, the ab-
dominal aorta was dissected just caudal to the left renal
artery and above the bifurcation of the aorta. The aorta was
then encircled with a silk ligature both distal to the renal
artery and proximal to the bifurcation to facilitate secure
occlusion. Animals were anticoagulated with 200 units/kg
of heparin before aortic cross-clamping. The aorta was
occluded distal to the left renal artery and proximal to the
bifurcation with atraumatic vascular clamps to induce spinal
cord ischemia.13 After completion of the ischemia period,
ligatures and cross-clamps were removed, the abdomen was
closed in 2 layers, and the animals were allowed to recover.
After the operations, the animals were returned to their
cages and allowed free access to water and food. Sham-
operated animals underwent same procedures without ad-
ministration of tested drugs and induction of SCI by aortic
occlusion.Experimental groups
After anesthesia and baseline hemodynamic measure-
ments, rabbits were placed in 1 of the 5 groups. Animals in
group S underwent a sham operation. The control group
(group C) received vehicle (50% alcohol, 2 mL) 30 minutes
before the 30-minute SCI period whereas animals of
groups R1 and R10 received resveratrol (Sigma, St. Louis,
Mo)—1 and 10 mg/kg dissolved in 2 mL 50% alcohol,
again 30 minutes before SCI. All groups underwent 30
minutes of aortic occlusion. The vehicle and resveratrol
solution were infused in 5 minutes in all animals. The
resveratrol infusion doses were selected according to the
doses used in brain ischemia models in the literature.14,15
Data collection
Temperature and hemodynamic measurements were
recorded at following timepoints: after anesthesia, after
laparotomy, during cross-clamping, after removal of the
cross-clamp, and after closure. Arterial blood samples for
nitrite/nitrate measurements were drawn immediately after
insertion of the arterial catheter (before the administration
of test drug) (preischemia), 2 minutes before the removal of
the cross-clamp (ischemia), and after skin closure (postisch-
emia).
Neurologic evaluation
Neurologic status was scored by assessment of hind-
limb neurologic function 48 hours after the procedure,
using the modified Tarlov Scoring System.16 Neurologic
status of animals was assessed blindly by 2 researchers.
Crede’s maneuver was used for evacuation of the urinary
bladder when necessary.17 A score of 0 to 5 was assigned to
each animal as follows: 0, no voluntary hind-limb move-
ment; 1, movement of joints perceptible; 2, active move-
ment but unable to sit without assistance; 3, able to sit but
unable to hop; 4, weak hop; 5, complete recovery of hind-
limb function.
Histopathologic evaluation
All rabbits were sacrificed by using sodium pentobarbi-
tal (100 mg/kg) and KCl administered intravenously
through an ear vein at the 48th hour of reperfusion. The
lumbar spinal cord segment was immediately procured and
flash-fixed in 10% buffered formalin for 15 days. Segments
were embedded in paraffin, and serial transverse sections
were cut (4 ) for hematoxylin and eosin staining. His-
topathologic evaluations were performed by a pathologist
blinded to the study groups. Histopathologic sections were
evaluated both by qualitative and quantitative methods in
order to maximize scientific accuracy. Histologic damage
was scored qualitatively, using a previously defined sys-
tem.18 A score of 1 to 5 was assigned to each section as
follows: 1, frank necrosis; 2, severe cellular damage; 3,
moderate cellular damage; 4, mild cellular damage; and 5,
normal histologic appearance. As a quantitative method,
the neuronal viability index was also calculated.19 Features
consistent with neuronal injury included eosinophilic cyto-
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July 2004140 Kiziltepe et alFig 1. Histopathologic findings of anterior horn of lumbar spinal cord segments procured 48 hours after reperfusion
and stained with hematoxylin-eosin. A, Normal appearance of neurons in sham operated animals (arrows, Nissl
substance, 40). B, Eosinophilic neuronal degeneration in group C, exhibiting inflammatory cell accumulation,
destruction and vacuolization of the gray matter, pyknosis of neurons and capillary proliferation (single arrows, necrotic
neuron bodies without Nissl substance; double arrow, new capillary vessels [neovascularization]; 40).
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structure). Cells that contained Nissl substance in the cyto-
plasm, loose chromatin, and prominent nucleoli were consid-
ered viable. The viability index was calculated as the number of
clearly viable neurons divided by the total neuronal count
within the anterior horn of each section for each animal.
MDA measurements
As a marker of oxidative stress and FOR-mediated
damage, MDA levels were measured at the lumbar seg-
ments of spinal cords that were removed from sacrified
animals at the 48th hour of reperfusion. Samples were
stored at 70°C until the analysis. Each sample was ho-
mogenized in 100 mmol/L phosphate buffer (pH 7.4) in
an ice bath. The homogenate was sonicated 2 times for 20
seconds and centrifuged. Fifty L of sample was added to a
mixture containing 200 L phosphate buffer solution,
0.88 % buthylated hydroxytoluene, and trichloroacetic acid
(30 %). After mixing, samples were kept at 4°C for 2
hours and then centrifugated at 4000 rpm for 15 minutes.
Two hundred and fifty L of supernatant was added to a
mixture 0.1 mol/L EDTA-NaH2O and thiobarbituric acid
(1%) and then boiled for 15 minutes. The absorbance of the
mixture was measured at 490 nm with microplate reader
(ELX-800, Bio-Tek). MDA concentrations in the samples
were calculated by a standard calibration curve of 1,1,3,3-
tetraethoxypropone prepared in the same manner. Each
measurement was performed in duplicate. MDA concen-
trations were expressed as mol/L.
Fig 1 (continued). C, Near to normal appearance of an
protected Nissl substance (arrows, 400).Nitrite/nitrate measurements
Plasma concentrations of nitrite/nitrate were assayed
with a commercially available nitric oxide assay kit (Assay
Designs, Inc, Ann Arbor, Mich). The kit allows the enzy-
matic conversion of nitrate to nitrite, by the enzyme nitrate
reductase, followed by colorimetric detection of nitrite as a
colored azo dye product of the Griess reaction. We inves-
tigated to determine total NOx production; nitrate was
reduced to nitrite by reduced nicotinamide-adenine dinu-
cleotide in the presence of nitrate reductase and reading the
optical density at 540 nm.
Statistical analysis
All data are expressed as mean  standard deviation.
Statistical analysis of the neurologic scores, neuronal viabil-
ity index, histologic score, and MDA values were analyzed
by using Kruskal-Wallis one-way analysis of variance.
Where differences were identified, a multiple comparison
test20 was performed. Statistical analyses of hemodynamic
and temperature measurements were done with the un-
paired Student t test. Nitrite/nitrate measurements were
analyzed with the Friedman 2-way analysis of variance
followed by a multiple comparison test21 when significant.
All analyses were performed by using the SPSS software
package (SPSS, Inc, Chicago, Ill).
RESULTS
Perioperative data. Two animals both in groups C
and R1 and 3 animals in group R10 were dead before the
horn of lumbar spinal cord segments in group R10 withterior
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surgical complications intraoperatively.
Examination of the systolic blood pressure data re-
vealed that there was a transient and non-significant de-
crease in MAP in the groups R1 and R10 following resvera-
trol infusion (Table I).
All animals had a slight decrease in rectal temperature
after laparotomy followed by slow elevation back to pre-
laparotomy levels until the completion of experiment.
None of the animals had temperatures less than 37.5°C,
and rectal temperatures were similar in all groups.
Neurologic evaluation. Five animals in Group C had
paraplegia while 5 animals in Group R10 had normal or
near normal neurologic functions (Table II). The average
Tarlov score for group R10 was significantly higher than
that for group C. The difference between groups R1 and C
was not significant.
Histopathologic evaluation. No sign of spinal cord
damage was observed in hematoxylin-eosin–stained sec-
tions in the sham-operated rabbits (Fig 1, A). However, in
most of the control rabbits, histologic sections showed
severe neuronal damage, as evidenced by eosinophilic neu-
ronal degeneration, inflammatory cell accumulation, swol-
len motor neuron cells in which the Nissl bodies and nuclei
had disappeared, and vacuolization of gray matter (Fig 1,
B). Sections of rabbits that received 1 mg/kg resveratrol
showed only slightly improved histopathologic appearance.
In contrast, examinations of the most of the rabbits that
received 10 mg/kg resveratrol showed almost intact-look-
ing light microscopic findings with minimal inflammatory
cell accumulation (Fig 1, C). The histopathologic score of
animals in group R10 was significantly higher than that for
both groups R and C (Table III). Similarly viable neuron
count at the anterior lumbar spinal cord sections revealed a
higher neuronal viability index in group R10 compared
with both R1 and C (Table III).
Table I. Heart rate and systolic blood pressure values (mm
After
anesthesia
After
laparatomy
Group S
HR 297  11 300  10
SBP 87.5  4.3 87.1  2.3
Group K
HR 303  13 304  15
SBP 87.4  4.5 85.8  3.7
Group R1
HR 298  17 303  18
SBP 89.3  3.1 84.4  2.9
Group R10
HR 308  16 286  21
SBP 86.8  5.7 87.3  5.7
Group L
HR 298  11 301  22
SBP 92  6.4 84.5  9.2
HR, Heart rate; SBP, systolic blood pressure.
*P  .05, vs groups S, K, R1, and R10.
†P  .05, vs groups S and K.MDA levels. The MDA levels of R10 were signifi-
cantly lower than those of the group C (55  12.9
nmol/mg protein vs 83.9  15.1 nmol/mg protein, re-
spectively; P  .001)(Fig 2). The difference between
groups S and R10 was not significant (P  .065).
Nitrite/nitrate levels. The time courses of the ni-
trite/nitrate levels throughout the experiment are depicted
in Fig 3. The control group had decreased NO release
during the ischemia period (P  .01 vs preischemia) while
near to complete recovery occurred during reperfusion
phase. In contrast, group R10 had increased NO release
(P  .05) during ischemia, which decreased to baseline
during reperfusion. The time courses of groups R1 and
R10 were also significantly different compared with those
of groups C at the ischemia period (when calculated
changes between consecutive data points were compared:
group C vs group R1, P .05; group C vs group R10, P
.01) and reperfusion period (group C vs group R1, P .01;
group C vs group R10, P  .01).
DISCUSSION
Our findings revealed that preischemic infusion of 10
mg/kg resveratrol protected spinal cord from I/R injury as
evidenced by improved neurologic function and near nor-
mal histopathologic appearence. This protective effect was
not prominent in animals that received 1 mg/kg resvera-
trol. The time course of the nitrite/nitrate levels demon-
strated significantly increased NO release after resveratrol
infusion and return of NO levels to baseline in time. How-
ever, NO release of the control group decreased during
ischemia and recovered during reperfusion.
Reperfusion injury is one of the most important com-
ponents in the pathogenesis of neurologic dysfunction
following SCI. Reoxygenation of the energy-depleted cells
causes massive production of FOR. Peroxidation of mem-
brane lipids and loss of membrane functions result in cell
)
During cross-
clamping
After removal
of cross clamp After closure
– 297  8 298  8
– 87.7  3.9 87.3  5.6
300  14 309  13 313  13
86.5  5.3 84.3  4.4 86.7  4.5
268  25 296  19 280  24
87.3  2.8 85.6  5.1 84.5  7.2
259  17 293  17 285  15
88  3.9 85.1  3.2 84.2  4.8
318  25 306  19 311  19
82.2  11.9 74.3  10.7* 76.3  13.1†Hg
Comparison Test ).
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cytokines by microglia and activated neutrophils also con-
tributes to generation of these radicals.22,24 Another mech-
anism of neuronal death is excitotoxicity. Following SCI,
release of the excitotoxic transmitter glutamate and activa-
tion of N-methyl D-aspartate receptors cause excessive
Ca2 influx and trigger a chain of reactions that lead to
neuronal death.25
Resveratrol-induced brain protection has been demon-
strated by several authors, although we did not find any
report that investigated its effect against SCI. Its neuropro-
tective effect was attributed mainly to the protection mem-
branes with neutralization of FOR,26,27 as well as to im-
provement of brain perfusion.27 It was demonstrated that
resveratrol decreased oxidative stress by increasing heme
oxygenase activity28 and suppressed inflammatory response
by inhibition of interleukin-6 production in mixed glial
cells.29 In agreement with the previous statements, as evi-
dence of decrease of oxidative stress, we also documented
decreased levels of MDA in animals that received a high
dose of resveratrol as compared with the animals that
received vehicle. The decreased inflammatory cell accumu-
lation in the spinal cords of animals that received resveratrolas compared with the control group also supports resvera-
trol’s proposed antiinflammatory property and may con-
tribute to neuroprotection.
Potent in vivo antioxidant properties of resveratrol
were explained by its stimulation of NO formation12,30as
well as its role as a potent scavenger for FOR generated by
both neutrophils and endothelium.31,32 Some reports in-
dicate that NO is the mediator of resveratrol-induced pro-
tection against I/R injury in kidney and heart.32,33 Res-
veratrol increases NO production by upregulation of
endothelial NOS (eNOS) mRNA expression,12,34 and
slows its degradation.34 It produces both NO-mediated
and NO-independent vasorelaxation to improve perfusion
of tissues during reperfusion.11
Effects of NO on neural tissue is controversial: it has
been proposed to have dual action (neurotoxicity and
neuroprotection).6 Although some studies showed that
neurotoxicity is related to peroxynitrite formation6 and
glutamate-induced exitotoxicity,6,35 several others demon-
strated the presence of NO-mediated protection in neural
tissue.6,7,9 This phenomenon has been explained by several
mechanisms. NO, which itself is a free radical, behaves as a
potent antioxidant in vivo. It inhibits lipid peroxidation andTable II. Neurologic status 48 hours after reperfusion as
evaluated by the Tarlov neurologic recovery scale
Tarlov score*
Group S
(n  7)
Group C
(n  7)
Group R1
(n  7)
Group R10
(n  7)
0 0 5 1 0
1 0 0 1 0
2 0 0 1 1
3 0 0 1 1
4 0 1 1 1
5 7 1 2 4
Mean  SD 5 1.3  2.2 2.9  1.95 4.1  1.2†
Median 5 0 3 5
*0, No movement; 1, minimal movement; 2, sits with support; 3, sits without
support; 4, weak hop; 5, normal hop.
†P .014, vs group C (Kruskal-Wallis 1-way ANOVA followed by Multiple
16Table III. Quantitative and qualitative histopathologic analysis of spinal cord specimens at the 48th hour of reperfusion
Group S
(n  7)
Group C
(n  7)
Group R1
(n  7)
Group R10
(n  7)
Neuronal viability index* 1 0.46  0.34 0.45  0.28 0.82  0.24†
Median 1 0.41 0.37 0.89
Histopathologic score‡ 5 2.4  1.18 2.75  1.5 4.14  1.06§
Median 5 2 2.5 4
*Number of viable neurons divided by the total neuron count within the ventral spinal cord (quantitative).
†P  .018 group C vs group R10; P  .029 group R1 vs group R10. (Kruskal-Wallis 1-way ANOVA followed by Multiple Comparison Test16).
‡Histopathologic score (qualitative): 1, frank necrosis; 2, severe cellular damage; 3, moderate cellular damage; 4, mild cellular damage; 5, normal histologic
appearance.
§P  .015 group C vs group R10; P  .049 group R1 vs group R10 (Kruskal-Wallis 1-way ANOVA followed by Multiple Comparison Test16).Fig 2. Malondialdehyde levels of lumbar spinal cord segments
procured at the 48th hour of reperfusion. * P  .065, group R10
vs group S; P .001, group R10 vs group C; P .02, group R10
vs group R1. †P  .0005, groups R1 and R10 vs group S.
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originates from eNOS is required for mediation of ischemic
preconditioning–induced neuroprotection against I/R in-
jury, as documented in cerebral ischemia by Gidday et al .36
It has also been shown that NO-related S-nitrosylation
causes decreased N-methyl D-aspartate receptor activity
and caspase enzyme activity, thus providing neuroprotec-
tion from excitotoxic insults.6,37 In support of this hypoth-
esis, it has been shown that inhibition of NO synthesis
causes a decrease in cerebral blood flow,38 and an increase
in cerebral infarction volume.39
The data of Matsumoto et al9 revealed the importance
of NO in SCI as evidenced by aggravation of spinal cord
injury with nonselective NOS blockage by using L-NAME
(NG-nitro-L-arginine-methyl ester, a nonspecific nitric ox-
ide synthase inhibitor) in rabbits subjected to SCI. Our
results are in agreement with these findings and show
association of improved neurologic status and elevated NO
release in animals receiving 10 mg/kg resveratrol whereas
decreased levels of NO were associated with severe neuro-
logic deficit after SCI. Although not included in this study,
we attempted to neutralize the resveratrol-induced spinal
cord protection with L-NAME in 10 rabbits. These animals
received an L-NAME infusion (10 mg/kg) before resvera-
trol infusion (10 mg/kg). Unfortunately, all but 2 animals
unexplainably died in the early postoperative period due to
significant hemodynamic instability; thus we could not
demonstrate loss of the spinal cord protection with com-
bined use of L-NAME and resveratrol. However, nitrite/
nitrate data showed that L-NAME infusion suppressed
resveratrol-induced NO release and formed a parallel time
course to the control group.
The present study is probably one of the first to dem-
onstrate the effects of resveratrol in attenuating the I/R-
induced neurologic injury to the rabbit spinal cord. MDA
data suggest decreased oxidative stress as one of the most
Fig 3. Time course of nitrite/nitrate levels throughout
group R10 (P  .05 vs preischemia) whereas it decreas
absolute changes from baseline were compared, P .05,
the postischemia phase, previously decreased NO release
NO release decreased close to baseline values in groups R
absolute changes from ischemia values were compared, Ppossible mechanisms. Elevated NO release may also cause
decreased excitotoxicity and improved perfusion due to
vasodilation. This neuroprotection could be a form of
pharmacologic preconditioning that was induced by activa-
tion of eNOS, as suggested by Gidday et al.36 We also
propose that decrease of NO release to baseline, approxi-
mately 1.5 hours after resveratrol infusion, indicates the
need for a continuous infusion or another bolus dose
before reperfusion to further potentiate its protection
against ischemic spinal cord injury. Another conclusion
would be the inadequacy of the1 mg/kg dose of resvera-
trol.
Future studies investigating the abrogation of resvera-
trol-induced spinal cord protection with nonselective and
selective inhibitors of NOS may reveal the underlying
mechanism of this protection. The protection of resveratrol
against apoptosis may also be an important future research
interest. Further studies using different doses and timing of
resveratrol infusion are necessary to clarify the detailed
mechanism responsible for the beneficial effects of resvera-
trol infusion on SCI.
In this study, although we proved the protective role of
resveratrol, we could not fully explain the underlying mech-
anism. Our failure to document possible abrogation of the
effects of resveratrol by L-NAME is probably the major
limitation of this study. To explain the mortality of these
animals, different dose combinations of resveratrol and
L-NAME should be tried. We believe the higher mortality
of study groups (which is related to surgical complications
in almost half of the animals) is not related to SCI and did
not affect our results.
In conclusion, preischemic infusion of 10 mg/kg res-
veratrol protects the spinal cord from I/R injury in rabbits.
This protection is related to decreased oxidative stress and
can be a form of NO-mediated pharmacologic precondi-
tioning. L-NAME infusion may abrogate this protection.
experiments. *NO release increased during ischemia in
group C (P  .01 vs preischemia). †When calculated
p C vs group R; P .01, group C vs group R10. During
ed to increase in group C whereas previously increased
R10 (P .01 vs ischemia for group R). When calculated
1, group C vs group R; P .01, group C vs group R10.the
ed in
grou
start
and
 .0
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protection, correct dose, and timing of resveratrol, studies
of this red wine polyphenol in the prevention of neurologic
deficits associated with surgical procedures of the descend-
ing aorta in humans may be useful.
The authors thank Nazmiye Kursun for statistical anal-
ysis of the data.
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